SIC
SJS Investment Consulting’s Jazz Pharmaceuticals JAZZ Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $80.3K | Sell |
757
-5
| -0.7% | -$531 | 0.01% | 143 |
|
2025
Q1 | $94.6K | Buy |
762
+1
| +0.1% | +$124 | 0.02% | 143 |
|
2024
Q4 | $93.7K | Buy |
761
+1
| +0.1% | +$123 | 0.02% | 141 |
|
2024
Q3 | $84.7K | Buy |
760
+2
| +0.3% | +$223 | 0.01% | 150 |
|
2024
Q2 | $80.9K | Sell |
758
-2
| -0.3% | -$213 | 0.02% | 137 |
|
2024
Q1 | $91.5K | Buy |
760
+3
| +0.4% | +$361 | 0.02% | 137 |
|
2023
Q4 | $93.1K | Sell |
757
-1
| -0.1% | -$123 | 0.02% | 128 |
|
2023
Q3 | $98.1K | Buy |
758
+2
| +0.3% | +$259 | 0.02% | 110 |
|
2023
Q2 | $93.7K | Sell |
756
-1
| -0.1% | -$124 | 0.02% | 109 |
|
2023
Q1 | $111K | Sell |
757
-3
| -0.4% | -$439 | 0.03% | 102 |
|
2022
Q4 | $121K | Buy |
760
+5
| +0.7% | +$797 | 0.04% | 104 |
|
2022
Q3 | $101K | Buy |
+755
| New | +$101K | 0.03% | 117 |
|
2022
Q1 | $117K | Buy |
752
+2
| +0.3% | +$311 | 0.04% | 122 |
|
2021
Q4 | $96K | Buy |
+750
| New | +$96K | 0.03% | 128 |
|